About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
OncoImmunology
›
Top Articles
OncoImmunology
Oncology
,
Biology
,
Immunology
7.2
(top 2%)
Impact Factor
7.7
(top 2%)
extended IF
96
(top 4%)
H-Index
4.6K
authors
3.3K
papers
76K
citations
3.1K
citing journals
47.7K
citing authors
Most Cited Articles of OncoImmunology
Title
Year
Citations
Consensus guidelines for the detection of immunogenic cell death
2014
524
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
2016
367
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
2014
309
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan
2012
260
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
2014
259
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
2012
248
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors
2015
247
CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8 T cells
2013
239
Role of IL-2 in cancer immunotherapy
2016
212
TIM3FOXP3 regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
2013
193
Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-β and miR23a transfer
2016
186
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
2015
184
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
2015
182
First oncolytic virus approved for melanoma immunotherapy
2016
181
EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer
2017
177
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
2016
176
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
2012
173
Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy
2015
172
Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands
2012
167
A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab
2015
166
Trial watch: IDO inhibitors in cancer therapy
2014
166
Trial Watch: Experimental Toll-like receptor agonists for cancer therapy
2012
164
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
2012
163
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease
2012
163
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
2015
162
previous
2014
2015
2016
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.